Dermata Therapeutics, Inc. (DRMAW) SEC Filings — 2025

Filings

• Dermata Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 29, 2025
• Dermata Therapeutics Terminates Material Agreement — 8-K · Nov 18, 2025
• Dermata Narrows Q3 Loss, Boosts Cash Amid Reverse Stock Split — 10-Q · Nov 14, 2025
• Dermata Therapeutics, Inc. 8-K Filing — 8-K · Nov 7, 2025
• Dermata Therapeutics Files 8-K — 8-K · Sep 17, 2025
• Dermata Therapeutics Files 8-K: Other Events Reported — 8-K · Sep 10, 2025
• Dermata Therapeutics to be Acquired by 03 Life Sciences — 8-K · Aug 25, 2025
• Dermata Narrows Losses, Boosts Cash Amid Going Concern Doubts — 10-Q · Aug 13, 2025
• Dermata Therapeutics Files 8-K on Security Holder Rights — 8-K · Jul 30, 2025
• Dermata Therapeutics Files 8-K on Security Holder Vote — 8-K · Jul 16, 2025
• Dermata Therapeutics Faces Delisting Concerns — 8-K · Jul 7, 2025
• Dermata Therapeutics Files 8-K: Accountant Change — 8-K · Jun 5, 2025
• Dermata Therapeutics Files Proxy Statement Addendum — DEFA14A · Jun 2, 2025
• Dermata Therapeutics Files 8-K — 8-K · May 21, 2025
• Dermata Therapeutics Faces Delisting Concerns — 8-K · May 16, 2025
• Dermata Therapeutics Files Q1 2025 10-Q Report — 10-Q · May 14, 2025
• Dermata Therapeutics Files 8-K — 8-K · Apr 15, 2025
• Dermata Therapeutics Files 8-K: Material Agreements & Equity Sales — 8-K · Mar 28, 2025
• Dermata Therapeutics Files 8-K Report — 8-K · Mar 27, 2025
• Dermata Therapeutics Faces Delisting Notice — 8-K · Mar 25, 2025
• Dermata Therapeutics Files 2024 10-K, Highlights Cybersecurity — 10-K · Mar 17, 2025
• Dermata Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Jan 23, 2025
• Dermata Therapeutics Files 8-K for Material Agreement — 8-K · Jan 21, 2025